The risk scores increased significantly with the progression of the clinical T-stage, pathological stage, pathological grading, tumor free (the patient was tumor-free up to the follow-up cut-off time), the levels of alpha-fetoprotein, fibrosis Ishak score, and the status of vascular invasion (Fig. S1E–L). The gene discussed is AFP; the disease is neoplasm.